Avid Bioservices' stockholders approve transaction with GHO and Ampersand
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 30 2025
0mins
Stockholder Approval: Avid Bioservices' stockholders have approved the transaction with GHO Capital Partners and Ampersand Capital Partners during a special meeting.
Transaction Closure: With regulatory approvals in place, Avid expects to finalize the transaction in the coming days, providing immediate cash value to its stockholders.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
